# Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

> **NCT03733210** · PHASE1 · COMPLETED · sponsor: **Andrei Iagaru** · enrollment: 14 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck
- Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Panitumumab-IRDye800
- **DRUG:** 89-Zirconium (Zr-89) Panitumumab
- **DEVICE:** Pinpoint IR IR9000 fluorescence imaging system (FIS)
- **DEVICE:** SPY-PHI IR9000 fluorescence imaging system (FIS)
- **DEVICE:** Explorer Air camera
- **DEVICE:** PDE-NEO II camera
- **DEVICE:** FIS-00 fluorescence imaging system (FIS)
- **DEVICE:** Da Vinci Firefly Imaging System
- **DEVICE:** IGP-ELVIS-v4 Macroscopic Specimen Imager
- **DEVICE:** Vevo 3100 LAZR-X
- **DEVICE:** Pearl Triology Imaging System
- **DEVICE:** Odyssey CLx Imaging System
- **DEVICE:** Leica fluorescence microscope

## Key facts

- **NCT ID:** NCT03733210
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-07
- **Primary completion:** 2020-12-11
- **Final completion:** 2021-08-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733210, "Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03733210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*